Active substances
Magnesium acetate + Potassium acetate + Sodium chloride
- SFDA 4
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| MULTILYTE pH 5.5 solution for infusion | 0.320,1.28,2.34 mg/ml,mg/ml,mg/ml | Solution · Intravenous use | 1 Bottle | SAR 16.00 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| MULTILYTE pH 5.5 solution for infusion | 0.32,1.28,2.34 mg/ml,mg/ml,mg/ml | Solution · Intravenous use | 1 Bag | SAR 10.25 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| MULTILYTE pH 5.5 solution for infusion | 0.32,1.28,2.34 mg/ml,mg/ml,mg/ml | Solution · Intravenous use | 1 Bag | SAR 18.00 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| MULTILYTE pH 5.5 solution for infusion | 0.32,1.28,2.34 mg/ml,mg/ml,mg/ml | Solution · Intravenous use | 1 Bag | SAR 27.50 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.